Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
International Journal of STD & AIDS|February 20, 2026
Oral human papillomavirus and HIV: A cross-sectional study among men with same-sex sexual contact in NigeriaRebecca G Nowak, Kareshma Mohanty, Connor R Volpi, et al.
Msphere|November 2, 2022
Mucosal and Systemic Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Determined by Severity of Primary InfectionMohammad M Sajadi, Amber Myers, James Logue, et al.
Journal of Virology|June 19, 2015
Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1Neelakshi Gohain, William D Tolbert, Priyamvada Acharya, et al.
AIDS (London, England)|April 16, 2025
Penile human papillomavirus prevalence in circumcised sexual minority men living with and without HIVNginache Nampota-Nkomba, Kareshma Mohanty, Ruxton Adebiyi, et al.
Plos One|April 6, 2023
Maternal transfer of IgA and IgG SARS-CoV-2 specific antibodies transplacentally and via breast milk feedingMohammad M Sajadi, Narjes Shokatpour, Madeleine Purcell, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 5, 2020
Multifunctional Bio-Nanocomposite Coatings for Perishable FruitsSeohui Jung, Yufei Cui, Morgan Barnes, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 9, 2016
Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?Kaku A So-Armah, Janet P Tate, Chung-Chou H Chang, et al.
Ebiomedicine|July 24, 2025
Rapid, sensitive, and species-independent detection of Crimean Congo hemorrhagic fever virus nucleoprotein and GP38 antibodiesElif Karaaslan, Cheng-Feng Chiang, Gülter Öncü Kurutaş, et al.
Nature Communications|November 26, 2022
Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virusIan A Durie, Zahra R Tehrani, Elif Karaaslan, et al.
Vaccine|June 8, 2021
Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trialJoel V Chua, Charles Davis, Jennifer S Husson, et al.
Pageof 9